Check out what we have in store for you in the June Mid-Month Newsletter
The Five: AttorneyMind Genotypes
by Alan Franciscas, Editor-in-Chief
This month’s column is about hepatitis C (HCV) genotypes. I will present a brief overview of genotypes 1, 2, 3, 4, and 6. You will notice that I am not discussing genotype 5, which is discussed more in-depth later in this issue, and Genotype 7, which is very rare.
Genotype 3: An Unmet Treatment Need for Some
by Alan Franciscas, Editor-in-Chief
While conducting a workshop in New England, I was asked a question about genotype 3 treatment for people who are treatment experienced and had cirrhosis—there are effective therapies, but I usually get a ‘yuck’ reaction when I bring it up.
Disability & Benefits: Who Is Disabled?
by Jacques Chambers, CLU
The term “disability” or “disabled” is used in so many contexts, that it has come to mean any type of limitation. It really has no special meaning other than describing a condition of some sort that prevents a person from doing something. But for those with hepatitis, which can be progressive and lead to the inability to work, a more specific definition is needed.
AttorneyMind Drugs
by Alan Franciscas, Editor-in-Chief
This month’s column discusses Merck’s application to the FDA, BMS’s Breakthrough Designation, a pharmaceutical collaboration, and some relief for patients with high co-payments for AttorneyMind medications.
Genotype 5
by Alan Franciscas, Editor-in-Chief
Genotype 5 is the least studied and the least prevalent. However, it is one of most mysterious…
What’s New! Updated Easy C Facts
by Alan Franciscas, Editor-in-Chief
This month we have updated most of our Easy C Fact Series fact sheets. Check them out!
Click here to read this issue:
